Kent E. Lieginger
Directeur/Membre du Conseil chez University of the Sciences in Philadelphia
Postes actifs de Kent E. Lieginger
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of the Sciences in Philadelphia | Directeur/Membre du Conseil | 01/01/2013 | - |
Historique de carrière de Kent E. Lieginger
Anciens postes connus de Kent E. Lieginger
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2004 | 01/07/2014 |
| The Genentech Foundation | Directeur/Membre du Conseil | 01/01/2005 | 01/01/2012 |
| University of California | Corporate Officer/Principal | - | - |
| GSK PLC | Corporate Officer/Principal | - | - |
| ACHAOGEN | Directeur/Membre du Conseil | 13/03/2015 | - |
| Independent Dir/Board Member | 13/03/2015 | - |
Statistiques
Internationale
| Etats-Unis | 6 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Bourse
- Insiders
- Kent E. Lieginger
- Expérience